A primary adrenal steroid, 11beta-hydroxyandrostenedione, has an osteotropic effect and little androgenic activity (Q31857645)

4 July 2017

title

A primary adrenal steroid, 11beta-hydroxyandrostenedione, has an osteotropic effect and little androgenic activity (English)

1 reference

4 July 2017

Suzuki Y

1

1 reference

4 July 2017

Nakagawa M

2

1 reference

4 July 2017

Sato F

3

1 reference

4 July 2017

Iichikawa Y

4

1 reference

4 July 2017

Mizushima Y

5

1 reference

4 July 2017

publication date

1 November 2000

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

4 July 2017

published in

1 reference

4 July 2017

volume

74

1 reference

4 July 2017

issue

4

1 reference

4 July 2017

page(s)

203-211

1 reference

In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Steroids and Bone Maturation in Infant Mice: Relative Activities of Dehydroepiandrosterone and Testosterone*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Biological Actions of Androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Adrenocortical steroids, bone mineral content and endometrial condition in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Declining adrenal androgens: an association with bone loss in aging women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Age, steroids and bone mineral content

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Bone deficit in ovariectomized rats. Functional contribution of the marrow stromal cell population and the effect of oral dihydrotachysterol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Androgens directly stimulate proliferation of bone cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900124-2

7 January 2021

10.1016/S0960-0760(00)00124-2

Identifiers

DOI

1 reference

4 July 2017

1 reference